Non-invasive versus ex vivo measurement of mitochondrial function in an endotoxemia model in rat: Toward monitoring of mitochondrial therapy by Wefers Bettink, M.A. (Mark A.) et al.
Contents lists available at ScienceDirect
Mitochondrion
journal homepage: www.elsevier.com/locate/mito
Non-invasive versus ex vivo measurement of mitochondrial function in an
endotoxemia model in rat: Toward monitoring of mitochondrial therapy
Mark A. Wefers Bettinka,⁎, Floor A. Harmsa, Nathalie Dolleea, Patricia A.C. Spechta,
Nicolaas J.H. Raata, G.C. Schoonderwoerdb, Egbert G. Mika
a Department of Anesthesiology, Laboratory of Experimental Anesthesiology, Erasmus University Medical Center Rotterdam, ‘s‐Gravendijkwal 230, 3015 CE Rotterdam, the
Netherlands
bDepartment of Clinical Genetics, Laboratory of Clinical Genetics, Erasmus University Medical Center Rotterdam, ‘s‐Gravendijkwal 230, 3015 CE Rotterdam, the
Netherlands
A R T I C L E I N F O
Keywords:
Mitochondria
Endotoxemia
Lipopolysaccharides
Succinic Acid
5-Aminolevulinic acid
A B S T R A C T
Mitochondrial function has been predominantly measured ex vivo. Due to isolation and preservation procedures
ex vivo measurements might misrepresent in vivo mitochondrial conditions. Direct measurement of in vivo mi-
tochondrial oxygen tension (mitoPO2) and oxygen disappearance rate (ODR) with the protoporphyrin IX‐triplet
state lifetime technique (PpIX-TSLT) might increase our understanding of mitochondrial dysfunction in the
pathophysiology of acute disease.
LPS administration decreased mitochondrial respiration (ODR) in vivo but did not alter mitochondrial func-
tion as assessed with ex vivo techniques (high resolution respirometry and speciﬁc complex determinations).
PpIX-TSLT measures in vivo mitoPO2 and ODR and can be applied non-invasively at the skin.
1. Introduction
Acute changes in mitochondrial function may play a role in the
pathophysiology of sepsis (Fink, 2002). However, the options for
monitoring mitochondrial function in patients are limited since only ex
vivo techniques are available. The most common ex vivo technique
measures oxygen consumption using oxygen electrodes (Estabrook,
1967), such as high‐resolution respirometry (Gnaiger et al., 1995).
Respirometry measures oxygen consumption in suspensions of isolated
cells, isolated mitochondria or homogenates of small tissue biopsies
and, therefore, might not adequately reﬂect the in vivo situation in
acute changes of mitochondrial function (Jeger et al., 2013). A new
non-invasive method to measure mitochondrial function could there-
fore improve the diagnosis of sepsis, and maybe even open the door to
new therapies for which there is an urgent need (Jeger et al., 2013).
Techniques to study mitochondrial function in vivo are the Nuclear
Magnetic Resonance (NMR)-technique and NADH ﬂuorometry
(Fosslien, 2001). NMR and NADH ﬂuoroscopy both show determinants
of metabolic state. The current inability of bedside monitoring and its
costs make NMR less suitable for clinical use.
Changes of mitochondrial metabolic states measured by NADH
ﬂuoroscopy have been shown in a research setting. Despite these re-
sults, standard clinical monitoring of mitochondrial function by NADH
ﬂuoroscopy is not yet an option due to its sensitivity to artifacts and
diﬃcult interpretation.
An innovative method to monitor mitochondrial function in vivo has
been developed and evaluated in our laboratory (Harms et al., 2013).
The protoporphyrin IX‐triplet state lifetime technique (PpIX‐TSLT) en-
ables measurement of mitochondrial oxygen tension (mitoPO2) in living
cells and tissues (Mik et al., 2006, 2008). Further development of this
technique allowed the detection of mitoPO2 and mitochondrial oxygen
disappearance rate (ODR) in the skin in vivo (Harms et al., 2011, 2012,
2013). Recently, the COMET monitor (Photonics Healthcare B.V.,
Utrecht, The Netherlands) has become commercially available. This
device allows measurements of mitoPO2 and ODR non-invasively in
healthy volunteers and patients at the bedside based on PpIX-TSLT
(Baumbach et al., 2018; Ubbink et al., 2016).
In two previous studies with the PpIX-TSLT we have measured a
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decreased ODR in the skin of LPS-induced rats (Harms et al., 2015a,
2015b). The eﬀect of LPS administration causes macrohemodynamic
and microcirculatory changes and inhibits mitochondrial complex I
(Choumar et al., 2011). Until now, we did not directly compare an ex
vivo muscle biopsy with our in vivo technique. This study therefore aims
to perform this direct comparison of in vivo and ex vivo data in a
clinically relevant model of sepsis.
Monitoring changes in ODR with the PpIX-TSLT during en-
dotoxemia, as a model for sepsis, is promising. Showing changes in in
vivo mitochondrial function due to an intervention would strengthen
the PpIX-TSLT as a monitor. In classic respirometry the substrate suc-
cinate is used to study mitochondrial oxygen consumption linked to
electron ﬂow through complex II (Silva and Oliveira, 2011). In isolated
mitochondria from endotoxemic rats the addition of succinate resulted
in a normalization of mitochondrial oxygen consumption (Protti et al.,
2007). We therefore measured with PpIX-TSLT whether succinate had
similar eﬀects on the mitochondrial respiratory chain in vivo in a rat
model of endotoxemia with succinate pre-treatment.
Until now, two important questions remained unanswered. The ﬁrst
question is how our PpIX-TSLT measurements in skin relate to in vivo
and ex vivo measurements in muscle, as the standard tissue for mi-
tochondrial biopsies and measurements (experiment A). The second
question is whether measurements performed with PpIX-TSLT besides
detection of gross changes in mitochondrial respiration, are also sen-
sitive enough to monitor therapeutic eﬀects (experiment B). Successful
in vivo measurement of mitochondrial parameters could help unravel
the pathophysiology involved in critical illness. Additionally, it would
provide a new technique for guiding therapies aimed at improving
mitochondrial function.
2. Material and methods
2.1. Subjects and preparation
The experimental protocols (A; DEC 129‐14‐03 and B; DEC
129‐12‐11) were approved by the Animal Research Committee of the
Erasmus University Medical Center Rotterdam. Animal care and
handling were performed in accordance with the guidelines for
Institutional and Animal Care and Use Committees.
For this study, 54 male Wister rats (Charles River, the Netherlands;
body weight 280‐350 g) were used, 14 rats in protocol A (age
77–111 days) and 40 rats in protocol B (age 59–73 days). Anesthesia
was induced by an intraperitoneal injection of a mixture of ketamine
90 mg kg−1 (Alfasan, Woerden, the Netherlands), medetomidine
0.5 mg kg−1 (Sedator, Eurovet Animal Health BV, Bladel, the
Netherlands) and atropine 0.05 mg kg−1 (Centrofarm Services BV,
Etten‐Leur, the Netherlands). Tracheotomy was performed to enable
mechanical ventilation. Ventilator settings were adjusted on end‐tidal
PCO2, keeping the arterial CO2 partial pressure between 35‐45 mmHg;
the inspired oxygen concentration was set at 40%. The right jugular
vein was catheterized with a polyethylene 0.9 mm catheter for in-
travenous ﬂuid administration. The left femoral artery was catheterized
to monitor arterial blood pressure and heart rate, and for hourly blood
gas analysis. Cardiac output was measured by a thermodilution method
with a thermistor inserted in the right carotid artery. Anesthesia and
ﬂuid balance were maintained by continuous infusion of ketamine
(50 mg kg−1h−1), a crystalloid (Ringer's, B. Braun Melsungen AG,
Melsungen, Germany) and a synthetic colloid solution
(2.5 ml kg−1h−1) (Voluven®, Fresenius Kabi, Bad Homburg, Germany).
Body temperature was measured rectally and maintained at
38 ± 0.5°C by means of a heating pad.
2.2. Experimental procedures
Abdominal hair was removed by shaving followed by application of
commercially available hair removal cream (Veet, Reckitt Benckiser
Co., Slough, UK) for about 5 min. PpIX was induced by applying a
freshly prepared 2.5% 5‐aminolevulinic acid (ALA) (Sigma‐Aldrich, St.
Louis, MO, USA) in hydrophilic cremor lanette (Lanettecreme I FNA,
Bipharma, Weesp, the Netherlands). The skin was covered with alu-
minum foil to protect PpIX from light exposure.
2.3. Experiment A; with muscle measurement
The skin above the m. quadriceps femoris was removed. The ALA
applied on the skin and muscle were covered with an adhesive ﬁlm to
avoid oxygen diﬀusion from the surroundings. The ALA applied tissue
was covered with aluminum foil to protect PpIX from light exposure.
The 14 rats were divided into 2 groups; a time-control group
(M−TC, N = 6) and a LPS‐induced endotoxemic group (M−LPS,
N = 8). TC were matched on duration of the experiment, a lactate
concentration above 2 mmol/l in the blood gas analysis was used as a
marker for the second ODR measurement in the LPS group. Fluid re-
suscitation (Voluven®, 5 ml*kg−1*h−1) was given to prevent hemo-
dynamic shock and a decline in mitoPO2. In the LPS group endotoxemia
was induced by intravenous LPS injection (4.5 mg/kg lipopoly-
saccharide from E.Coli 0127:B8, Sigma‐Aldrich, St. Louis, MO, USA).
After recording baseline values (T0), a solution of 1 mg/ml LPS was
infused during 30 min. Fluid resuscitation was performed by doubling
the maintenance colloid infusion directly after LPS application. The
timeline of this experiment is shown in Fig. 1A.
2.4. Experiment B; without muscle measurement
The 40 rats were randomly divided into 5 groups (8 rats/group);
two control groups consisting of a time control group (TC) and a control
group receiving methyl-succinate (SC). Three LPS‐induced endotoxemic
groups consisting of a group in which only LPS was given (LPS -‐), a LPS
group receiving ﬂuid resuscitation (LPS+‐), and a LPS group receiving
ﬂuid resuscitation and methyl-succinate (LPS++). Fluid resuscitation
(Voluven®, 5 ml*kg−1*h−1) was given to prevent hemodynamic shock
and a decline in mitoPO2. Succinate dimethyl ester (Brunschwig
Chemie, Amsterdam, the Netherlands) was infused (concentration
0.67 M, rate 5 ml*kg−1*h−1) 2 h prior to the LPS infusion in the SC and
LPS ++ groups. For the remaining groups, the succinate solution was
exchanged for saline at the same rate.
In all three LPS groups endotoxemia was induced by intravenous
LPS injection (3 mg/kg lipopolysaccharide from E.Coli 0127:B8,
Sigma‐Aldrich, St. Louis, MO, USA). After recording baseline values
(T0), a solution of 1 mg/ml LPS was infused during 15 min. Fluid re-
suscitation was performed by doubling the maintenance colloid infu-
sion directly after LPS application and by an additional ﬂuid bolus of
1 ml during 10 min prior to T1. The timeline of the experiment is shown
in Fig. 1B.
2.4.1. Principle of MitoPO2 and oxygen disappearance measurements
The background of the PpIX-TSLT is described in detail elsewhere
(Mik et al., 2006, 2008). In short, PpIX is the ﬁnal precursor of heme in
the heme biosynthetic pathway. PpIX is synthesized in the mitochon-
dria, ALA is the rate-limiting step in this pathway and therefore ad-
ministration enhances the PpIX concentration substantially. PpIX pos-
sesses a triplet state that reacts strongly with oxygen, making its
delayed ﬂuorescence lifetime oxygen-dependent according to the Stern-
Volmer equation (Mik et al., 2002).
The oxygen disappearance rate is measured directly after local oc-
clusion of the oxygen supply. The reﬂection probe was mounted on a
height-adjustable frame, above the ALA-treated skin, providing dif-
ferent settings of the probe distances to the skin. Local occlusion of the
microcirculation in the skin was obtained by local pressure with the
measurement probe. This simple procedure created reproducible stop-
ﬂow conditions and induced measurable oxygen disappearance rates,
due to cessation of microvascular oxygen supply and ongoing cellular
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oxygen consumption. MitoPO2 was measured before, during and after
application of pressure at an interval of 1 Hz and using 1 laser pulse per
measurement. We have described the fundamental principles behind
the technology and have provided a working implementation of the
technique for ODR measurements in vivo (Harms et al., 2013) and a
method to calculate ODR from the mitoPO2 kinetics. On each time point
mitoPO2 and ODR are presented as average of 4 replicate measure-
ments. In the time control group at T1 a starting mitoPO2 of around
50 mmHg was chosen, to match the LPS group, for ﬁtting of the ODR.
This was done to prevent potential negative eﬀects of increased noise at
higher mitoPO2 readings on ODR.
2.5. Mitochondrial assay in muscle biopsies
At the end of the experiment a muscle biopsy was taken from the m.
quadriceps femoris. The biopsy was transferred to mitochondrial
respiration buﬀer (MRB, a hybrid buﬀer consisting of 110 mM sucrose,
60 mM potassium lactobionate, 20 mM taurine, 10 mM monobasic
potassium phosphate, 3 mM magnesium chloride, 20 mM HEPES, 1 mM
EGTA, and 0.1% (w/v) BSA at pH 7.1 at 37°C) on ice, homogenized
using a Potter-Elvehjem PTFE pestle and glass tube, and injected in the
respirometer. A small piece of muscle was snap-frozen in liquid ni-
trogen and stored at −80°C for later determination of complex con-
centration and activity.
2.5.1. High-resolution respirometer
Oxygen consumption was measured using a high-resolution re-
spirometer (Oxygraph O2k, Oroboros, Innsbruck, Austria). Prior to
homogenate loading the instrument was calibrated following the
manufacturer instructions and loaded with 2.1 ml MRB. An oxygen
solubility in water of 0.92 was used to calculate oxygen levels. 0.1 ml of
muscle homogenate was added to the respirometer, and the chamber
Fig. 1. Schematic timeline of the experimental protocol. Panel A: Experiment A. with muscle measurement. M−TC: time control, M−LPS: endotoxemia with ﬂuid
resuscitation. Panel B: Experiment B. without muscle measurement. TC; time control, SC; succinate control, LPS ‐‐; endotoxemia, LPS +‐; endotoxemia with ﬂuid
resuscitation, LPS ++; endotoxemia with ﬂuid resuscitation and succinate. ALA; 5‐ aminolevulinic acid, LPS; lipopolysaccharide, T0 and T1 are the time points of
mitoPO2 and ODR measurement.
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was closed. All chemicals for the respirometer experiments were ob-
tained from Sigma-Aldrich (Darmstadt, Germany). To determine mi-
tochondrial complex activity, ﬁrst pyruvate (5 mmol/l ﬁnal con-
centration) and malate (2 mmol/l ﬁnal concentration) were added.
Subsequent addition of ADP (0.25 mmol/l ﬁnal concentration) showed
full activity of complex 1. After addition of rotenone (0.5 micromol/l
ﬁnal concentration) to the chamber complex 1 activity was stopped and
succinate (5 mmol/l ﬁnal concentration) was added to measure com-
plex 2 activity. The ATPase was inhibited by adding oligomycin (2.5
micromol/l ﬁnal concentration) and subsequently FCCP (1 mmol/l so-
lution) titration was performed to determine maximal oxygen con-
sumption. The oxygen consumption measured by the high-resolution
respirometer was corrected for citrate synthase activity, an indicator of
the number of mitochondria was measured according to Srere (1969)
(Srere and Lowensteijn, 1969) of the homogenate to enable objective
comparison between samples.
2.5.2. Complex determination
To obtain an indication of the function of the oxidative phosphor-
ylation the activity of citrate synthase (CS) and the activity of complex
1 and 2 were analyzed. Activities of the complexes were based on the
amount of CS to make objective comparison possible.
Tissue homogenates were prepared from frozen muscle in 0.25 M
sucrose, 10 mM N-[2-hydroxyethyl] piperazine-N′-[2 ethylsulfonic
acid](HEPES) and 1 mM Ethylene Diamine Tetraacetic Acid (EDTA), pH
7.4. Enzyme activities were measured in the homogenates. Activities of
the complexes of the mitochondrial respiratory chain were determined
in muscle homogenates by spectrophotometric methods as described
before (Scholte et al., 1995) Complex I or NADH-Coenzyme Q reductase
was determined kinetically by following the rotenon sensitive decrease
in the amount of NADH. Complex II or Succinate Coenzyme Q reductase
was measured by following the TTFA dependent reduction of DCPIP
after addition of succinate. Citrate synthase was used as an indicator for
the number of mitochondria to enable an objective comparison.
2.5.3. Statistical analysis
In experiment A data are expressed as median with interquartile
range. For intragroup analysis the Wilcoxon matched pair signed rank
test was used, for intergroup analysis the Mann-Whitney test was used.
For experiment B data are expressed as means with standard deviation
(SD), unless stated otherwise. A paired t-test was used to detect in-
tragroup diﬀerences. Two-way ANOVA with repeated measurements,
using post hoc multiple comparison with Bonferoni correction, was
used to detect intergroup diﬀerences. For the hemodynamic data only
intergroup diﬀerences were tested compared to time control. Normality
was tested by Q-Q analysis and the Shapiro-Wilk test. A p-value < 0.05
was considered statistically signiﬁcant. Statistical calculations were
performed using Graphpad Prism version 6.0 (GraphPad Software, La
Jolla, CA, USA).
3. Results
3.1. Experiment A
3.1.1. Hemodynamic parameters
Table 1 presents data on hemodynamic parameters of experiment A.
At baseline (T0) all rats were hemodynamically stable and no sig-
niﬁcant diﬀerence was observed between the groups. Three hours after
LPS infusion heart rate (p = 0.0293) and lactate (p = 0.0007) in-
creased compared to the time-control group.
3.1.2. MitoPO2 measurements
In accordance with previous experiments (Harms et al., 2015a), the
application of ALA increased the amount of PpIX in the mitochondria to
detectable levels in all animals. MitoPO2could be measured in the ab-
dominal rat skin for the duration of the experiment (3 h after
application of ALA). MitoPO2 in the abdominal skin didn’t change for
3 h (T0 → T1) in both the time control (M−TC) and endotoxemia
(M−LPS) group (Fig. 2A). However, muscle mitoPO2 at T1 in the
M−TC group was markedly higher, 82 [42] mmHg vs 46 [27] mmHg,
compared to the M−LPS group (Fig. 2B).
3.1.3. ODR measurements
ODR was derived from the mitoPO2 slope during blockage of mi-
crocirculatory blood ﬂow. At T0 the initial mitoPO2 was approximately
60 mmHg. Blocking the microcirculation by local pressure with the
measurement probe caused a drop in mitoPO2from 55 mmHg to ap-
proximately 10 mmHg in 10 s, this resulted in a ODR of 5.8 mmHg*s−1
(Fig. 3). In experiment A, at baseline no diﬀerence was found in skin
and muscle between M−TC and M−LPS group (Fig. 2A and B). In
contrast, at T1, a signiﬁcant lower value was measured in skin (LPS;
−4.2 [3.0] mmHg*s−1 vs TC; −7.1 [1.5] mmHg*s−1) and in muscle
(LPS −6.7 [2.4] mmHg*s−1 vs TC −9.7 [0.5] mmHg*s−1) (Fig. 2B).
4. Mitochondrial assay in muscle biopsies
Muscle biopsies were performed at the end of the experiment. We
found no diﬀerence in complex 1 and 2 activity in the high-resolution
respirometer of the homogenized muscle in both groups, as shown in
Fig. 2C. We found no diﬀerence in complex activity corrected for citrate
synthase activity measured in the snap frozen biopsies.
4.1. Experiment B
4.1.1. Hemodynamic parameters
At baseline (T0) all rats were hemodynamically stable and no sig-
niﬁcant diﬀerence was observed between the groups, as shown in table
2. Three hours after LPS infusion (T1), signiﬁcant hemodynamic
changes were observed in the LPS groups, reﬂected by an elevation in
serum lactate levels in all three endotoxemia groups. A decrease in
mean arterial blood pressure (MAP) was seen in the LPS – and the LPS
++ group compared to TC, but not in the LPS + ‐ group. Cardiac
output decreased in the LPS – (p = 0.049) and LPS ++ (p = 0.039)
groups (102 ± 59 and 100 ± 39 bpm vs 140 ± 56 bpm TC) com-
pared to time control. The succinate control group showed a signiﬁcant
decrease in heart rate (p = 0.0245), 267 ± 11 vs 290 ± 13 bpm,
compared to time control.
4.1.2. MitoPO2 measurements
A mitoPO2 value around 60 mmHg was observed for all experi-
mental groups at T0. In the LPS – group a signiﬁcant decline in
mitoPO2from 62 ± 9 mmHg (T0) to 41 ± 12 mmHg (T1) was
Table 1
Hemodynamic parameters experiment A.
T0 T1
MAP (MmHg)
M−TC 95 [14] 80 [6]
M−LPS 93 [6] 89 [26]
Cardiac output (ml/min)
M−TC 118 [39] 142 [67]
M−LPS 148 [60] 167 [60]
Heart rate (bpm)
M−TC 286 [41] 271 [42]
M−LPS 284 [37] 314 [56]a
Lactate (mmol/L)
M−TC 1.1 [0.1] 0.9 [0.4]
M−LPS 0.9 [0.1] 2.4 [0.6]b
Values are median [IQR], M−TC, time control; M−LPS, endotoxemia + ﬂuid
resuscitation.
a = P<0.05 compared to TC.
b = P<0.001 compared to TC.
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measured. At T1 a signiﬁcant lower value of mitoPO2 was measured in
the LPS – and LPS +- (p = 0.0006) groups compared to time control, of
41 ± 12 mmHg (LPS –) and 54 ± 21 mmHg (LPS + -) compared to
74 ± 17 mmHg (TC) respectively (Fig. 4A). The individual changes in
mitoPO2are presented in Fig. 4B.
4.1.3. ODR measurements
The ODR measurements at baseline (T0) did not diﬀer signiﬁcantly
between the groups. In three groups ODR at T1 decreased compared to
the baseline measurement (T0); the succinate control decreased from
4.6 ± 1.2 mmHg*s−1 to 3.6 ± 0.5 mmHg*s−1, the LPS – group de-
creased from 4.5 ± 1.0 mmHg*s−1 to 2.4 ± 1.6 mmHg*s−1, and the
LPS +- group decreased from 4.2 ± 1.3 mmHg*s−1 to
3.1 ± 1.0 mmHg*s−. However, infusion of methyl-succinate main-
tained ODR in the endotoxemia group (LPS++) at baseline values
(Fig. 5).
5. Discussion
The major ﬁndings of this study are that in vivo respirometry and ex
vivo respirometry provide diﬀerent results in our endotoxemic rat
model and that PpIX-TSLT provides a sensitive means to measure as-
pects of mitochondrial function in vivo. LPS decreased in vivo muscle
ODR at the measured timepoints compared to a time control group, but
no eﬀect of LPS was found in ex vivo mitochondrial function tests. No
change in mitochondrial function was found using the high-resolution
respirometer nor using direct complex activity measurements. In an
LPS-induced rat endotoxemia model we showed a decrease in in vivo
mitochondrial function (ODR) using the PpIX-TSL technique, that could
be prevented by pre-treatment with methyl-succinate. This result con-
ﬁrms the previously measured beneﬁcial eﬀects of methyl-succinate in
ex vivo biopsies from endotoxemic rats (Protti et al.). In addition, it
shows the feasibility of the PpIX-TSLT as an in vivo monitoring tool to
determine the therapeutic eﬀect of mitochondrial targeted drugs.
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Fig. 2. Panel A: MitoPO2 and ODR measurements in skin at T0 and T1 in the diﬀerent experimental groups, ODR M−LPS (T1) vs M−TC (T1) (p = 0.0093) Panel B:
MitoPO2 and ODR in muscle at T0 and T1 in the diﬀerent experimental groups, mitoPO2 M−LPS T1 versus M−TC T1 (p = 0.127) and ODR decreased M−LPS T1 vs
M−TC T1 (p = 0.0127). Panel C: comparison of ﬂux (normalized) between complex 1 and complex 2 corrected for protein concentration, and comparison of
complex activity in the snap frozen muscle biopsy corrected for citrate synthase. TC; time control, LPS; endotoxemia with ﬂuid resuscitation, LPS; lipopolysaccharide,
ODR; mitochondrial oxygen disappearance rate. T0 and T1 are the time points of ODR measurement. Data are presented as median ± IQR, * signiﬁcant diﬀerence
compared to time control measurement (p < 0.05); (TC; 6 rats, LPS; 8 rats).
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The administration of LPS leads to inhibition of complex I of the
mitochondrial electron transport chain (Choumar et al., 2011), mea-
sured as a decrease of mitochondrial oxygen disappearance rate (Harms
et al., 2015a). We did not replicate the detrimental eﬀect of en-
dotoxemia on ex vivo mitochondrial respiration experiments as shown
by Protti et al. However, Protti et al used a diﬀerent model (cegal li-
gation and puncture) to initiate an endotoxemia with no ﬂuid re-
suscitation. Furthermore, their experiment lasted longer and they only
used clinical severity grade as a marker for sepsis at 48 h. This dis-
crepancy with our results might imply that changes in ODR precede the
changes measured with ex vivo mitochondrial function tests.
In the measurement of mitoPO2 directly on the muscle a marked
increase of mitoPO2 on T1 was found compared to T0 in the time
control group but not in the LPS treated group. In 6 h a wound starts
with it ﬁrst phases of the healing process, it is unclear if a higher or
lower oxygen concentration is expected since both are mentioned
(Gottrup et al., 1984; Niinikoski et al., 1972). Endotoxemia has a
marked diminutive eﬀect on the pathophysiology of wound healing,
this may explain the relatively low mitoPO2 found in the LPS group
compared to the time control group (Kawaguchi et al., 1995).
In our in vivo respirometry experiments, the administration of LPS
resulted in decreased ODR. Fluid resuscitation in the LPS+‐ group
prevented macro-hemodynamic deterioration, although a signiﬁcant
lower value of mitoPO2 was found compared to time control, this may
be in part explained by a relatively high mitoPO2 found in the time
control group at T1. A decrease in MAP and cardiac output often occurs
after rapid and/or long‐term LPS infusion (Harms et al., 2015a). In all
our endotoxemia groups, lactate was signiﬁcantly higher compared to
the control groups. Lactate is only a crude marker of disease, depicting
the balance between aerobic and aerobic metabolism in the tissues at
the one site and on the other site an indication of slowing of liver
metabolism. An increase of mitoPO2 in the time control group, although
not signiﬁcant, may overestimate the changes found compared to the
other experimental groups. The mitoPO2 of 74 ± 17 mmHg at T1 in
the time control group may be explained by a relative liberal ﬂuid re-
gime (succinate infusion was replaced with extra saline infusion in the
other groups) used in this experiment. A constant mitoPO2 in the suc-
cinate control group indicates unaltered and adequate tissue oxygena-
tion. Despite maintained mitoPO2values at T1, the ODR of the succinate
control group, the LPS – group and the LPS with ﬂuid resuscitation
group (LPS + -) showed a signiﬁcant decrease compared to baseline
measurements. Unclear is why succinate decreased ODR slightly com-
pared to baseline, of interest is the decline of standard deviation com-
pared to time control. Moreover, no intergroup diﬀerences were found
on T1 in the ODR measurements. However, the greatest diﬀerence was
observed between the LPS +- and the succinate and ﬂuid resuscitated
LPS-group (LPS++), in which ODR values did not decline from base-
line values. Importantly, previous PpIX‐TSLT measurements showed
that mitochondrial respiration is independent of mitoPO2 levels (Harms
et al., 2013). Therefore, a distinction between problems related to
oxygen supply or oxygen consumption on the cellular level in critical
illness could be made using the PpIX-TSLT technique.
Several mitochondrial respiration studies have shown that mi-
tochondrial oxygen consumption recovers after administration of suc-
cinate (Protti et al., 2007; Silva and Oliveira, 2011). Protection of ODR
by methyl-succinate administration can be explained by several eﬀects.
Methyl-succinate could increase mitochondrial membrane perme-
ability, increase substrates in the citric acid cycle, or increase the ac-
tivity of complex II.
In our in vivo experiments, the infusion of methyl-succinate in the
LPS‐treated rats (LPS++) prevented a decline in ODR from baseline
values. This demonstrates that in vivo ODR measurements are able to
show changes in mitochondrial respiration which are subtler than
changes in lactate. We reproduced the beneﬁcial eﬀect of methyl-suc-
cinate on mitochondrial oxygen consumption as previously found in
isolated mitochondria (Protti et al.). We therefore think that our novel
measurement method enables eﬃcient monitoring of in vivo changes in
mitochondrial respiration.
In our study, methyl-succinate was already administered before the
LPS mediated endotoxemia was induced, which is not comparable to
the clinical situation. Therefore, our data mainly demonstrates the
feasibility of our experimental technique to detect subtle changes in
mitochondrial respiration. Further research is needed to determine
whether the protective eﬀect of methyl-succinate is still present when
administered after endotoxemia has already developed.
The clinical applicability of PpIX‐TSLT (Harms et al., 2016; Mik,
2013) allows non‐invasive real time monitoring of mitochondrial
Fig. 3. Typical example of in vivo mitochondrial respirometry measured at T0
on the abdominal skin of a rat. The ODR was determined from the linear part of
the oxygen disappearance curve by ﬁtting equation 2. MitoPO2 was the mean
mitoPO2 before the start of tissue compression.
Table 2
Hemodynamic parameters experiment B.
T0 T1
MAP (MmHg)
TC 107 ± 8 90 ± 11
SC 97 ± 15 80 ± 7
LPS ‐‐ 100 ± 12 73 ± 15a
LPS +‐ 102 ± 11 81 ± 13
LPS ++ 103 ± 10 71 ± 4a
Cardiac output (ml/min)
TC 153 ± 58 140 ± 56
SC 145 ± 62 135 ± 55
LPS ‐‐ 158 ± 26 102 ± 59a
LPS +‐ 165 ± 34 148 ± 46
LPS ++ 126 ± 35 100 ± 39a
Heart rate (bpm)
TC 263 ± 19 290 ± 13
SC 258 ± 16 267 ± 11a
LPS ‐‐ 267 ± 20 294 ± 30
LPS +‐ 276 ± 16 306 ± 16
LPS ++ 259 ± 15 305 ± 15
Lactate (mmol/L)
TC 1.3 [0.3] 1.1 [0.3]
SC 0.9 [0.5] 1.0 [0.3]
LPS – 1.1 [0.5] 2.6 [1.5]a
LPS+- 1.3 [0.4] 1.8 [1.3]a
LPS ++ 1.2 [0.1] 2.5 [1.8]a
Values are means ± SD (MAP, heart rate and cardiac output), and for lactate;
median [IQR].
TC, time control; SC, succinate control; LPS –, endotoxemia; LPS +‐, en-
dotoxemia + ﬂuid resuscitation; LPS ++, endotoxemia + ﬂuid resuscita-
tion + succinate.
a = P < 0.05 compared to TC; Lactate tested with Kurskal-Wallis test with
Dunn’s test for multiple comparison.
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function. The absence of tissue damage and functional loss may over-
come some of the current disadvantages experienced with biopsies
(Jeger et al., 2013) and enables bedside monitoring. A limitation of the
technique is the need to build up the PpIX signal following ALA ap-
plication for at least 3 h (Harms et al., 2015b). The recent release of a
monitor based on the PpIX‐TSLT technique (Ubbink et al., 2016) pro-
vides a bedside clinical tool to monitor the deterioration and recovery
of mitochondrial function in critically ill patients. Other potential
clinical uses of PpIX-TSLT are related to resuscitation and blood
transfusion management (Römers et al., 2016).
In conclusion, we showed the feasibility to monitor changes in mi-
tochondrial respiration in endotoxemic rats by cutaneous PpIX‐TSLT
measurements. A decrease in ODR in the presence of preserved or re-
stored mitoPO2 suggests that mitochondrial dysfunction may be at the
basis of the metabolic failure in sepsis, even in the absence of hemo-
dynamic shock. The ability to measure mitochondrial ODR and
mitoPO2 in the clinical setting using bedside monitoring PpIX-TSLT is
expected to contribute to a better understanding of mitochondrial
dysfunction.
In addition, it will allow to monitor existing therapeutic approaches
and develop improved therapeutic approaches aimed at restoring
aerobic metabolism and cellular function.
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Fig. 4. Panel A: MitoPO2 at T0 and T1 in the diﬀerent experimental groups. Panel B: Percentage change in individual mitoPO2. TC; time control, SC; methyl-succinate
control, LPS –; endotoxemia, LPS +-; endotoxemia with ﬂuid resuscitation, LPS ++; endotoxemia with ﬂuid resuscitation and methyl-succinate administration, LPS;
lipopolysaccharide, mitoPO2; mitochondrial oxygen tension. T0 and T1 are the time points of the mitoPO2 measurement. Data are presented as mean ± SD, *
signiﬁcant diﬀerence compared to baseline measurement, # signiﬁcant diﬀerence compared to time control measurement (p < 0.05); (8 rats/group). LPS – T1 vs
LPS – T0 (p = 0.0015), LPS – T1 vs TC T1 (p < 0.0001) and LPS +- T1 vs TC T1 (p = 0.0006).
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